Aller au contenu

Publications scientifiques

  • article Oh J, Bhan V, Traboulsee A, Morrow SA, Lee L, Levin M, Casserly C, Freedman MS, Giacomini PS and Émond F, Smyth P, Clift F, Selchen D

    Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis

    Can J Neurol Sci 2024.

    DOI PUBMED
  • article Cherkasova MV, Fu JF, Jarrett M, Johnson P, Abel S, Tam R, Rauscher A, Sossi V, Kolind S, Li DKB, Sadovnick AD, Machan L, Girard JM, Emond F, Vosoughi R, Traboulsee A, Stoessl AJ

    Cortical morphology predicts placebo response in multiple sclerosis

    Sci Rep 12 (1), 2022.

    DOI PUBMED
  • article Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R

    Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

    Neural Regen Res 13 (11), 2018.

    DOI PUBMED
  • article Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R

    Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment

    Curr Med Res Opin 34 (8), 2018.

    DOI PUBMED
  • article Freedman MS, Selchen D, Arnold DL, Prat A, Banwell B, Yeung M, Morgenthau D, Lapierre Y and

    Treatment optimization in MS: Canadian MS Working Group updated recommendations

    Can J Neurol Sci 40 (3), 2013.

    DOI PUBMED